Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
– Conference Call and Webcast to be held Tuesday, September 2, 2025, at 8:00 a.m. ET –WALTHAM, Mass., Sept. 01,…